Chinese Clinical Trial Register (ChiCTR)
- Registry URL: http://www.chictr.org
- Registration URL: http://www.chictr.org/Site/Reg.aspx (or go to http://www.chictr.org, select 'English' and then select 'Registration' from the top menu)
- Funding Agency: West China Hospital, Sichuan University
- Managing Agency: Chinese Evidence-Based Centre, Chinese Cochrane Centre
The Advisory Board currently consists of experts from the Chinese Evidence-Based Medicine Centre and Chinese Cochrane Centre, Ministry of Health of China, and United Kingdom Cochrane Centre. The Board will be extended after the ChiCTR becomes a WHO ICTRP Primary Register. The Board will include representatives of the State Food and Drug Administration (SFDA), State Administration of Traditional Chinese Medicine of the People's Republic of China (SATCM), Chinese Medical Association (CMA), Chinese Medical Doctor Association (CMDA), key journals, etc. The role of the Board is to consult and advise.
- Does the Registry accept prospective registration of interventional clinical trials submitted by Responsible Registrants?
- Does the Registry have documented Standard Operating Procedures (SOPs)?
- Are mechanisms in place to ensure compliance with these SOPs? (eg staff training)
- Description of the compliance mechanisms:
- Does the Registry agree to participate in the development of Guidelines for Clinical Trial Registries?
- Can the Registry collect and publicly display the WHO Trial Registration Data Set (TRDS)?
Yes, Click here to view the details.
- Languages in which the registered information is displayed:
- What quality control measures does your Registry have in place to make sure that all 20 items in the WHO TRDS are as complete and accurate as possible?
A two-step procedure is used to control the quality. First, the initial control is performed by the assessor, who is responsible for verifying that the filled-in information matches with the 20 items and for advising on the design of the trial. Second, the final control is performed by the final checking group consisting of senior methodologists, statisticians, and clinicians.
- Does the Registry flag trials that do not provide the complete WHO Trial Registration Data Set at the time of initial registration?
- Does the Registry agree to submit the WHO Trial Registration Data Set, in English, to the Central Repository?
- Does the Registry agree to keep registered information up-to-date?
- Does the Registry agree to maintain a publicly accessible audit trail so changes made to the WHO Trial Registration Data Set can be tracked?
- Does the Registry agree to never to remove a trial once it has been registered?
- Does the Registry publicly disclose ownership, governance structure and not/for-profit status?
- The web address where this information is displayed:
http://www.chictr.org/Upload/ChiCTRpressE.pdf and http://www.chictr.org/Site/About.aspx (or go to http://www.chictr.org, select 'English' and then select 'About ChiCTR' from the top menu)
- Does the Registry agree to inform the WHO ICTRP Secretariat of changes that may be relevant to its status as a Collaborating Registry in the Registry Network?
- Is the Registry searchable over the Internet at no charge?
- Is the Registry open to all prospective registrants?
- From which countries will the Registry accept trials for registration?